SCHEMBL7280666

SCHEMBL7280666

CC[Si](C#Cc1ccc2nc(Cl)nc(NCCOC)c2c1)(CC)CC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.44
▸ APP P05067 2/20 0.41
▸ CYP1A2 P05177 10/20 0.41
▸ CYP3A4 P08684 10/20 0.41
▸ CYP2C19 P33261 7/20 0.41
▸ CLK4 Q9HAZ1 5/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ CYP2D6 P10635 6/20 0.39
▸ HSD17B10 Q99714 5/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ USP2 O75604 4/20 0.39
▸ ALOX15 P16050 3/20 0.39
▸ NCF1 P14598 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ TSHR P16473 5/20 0.37
▸ LMNA P02545 3/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7280272 0.80 PDE5A (0.52) —
SCHEMBL7297219 0.77 KDM4E (0.33) HTTALDH1A1KDM4ELMNAMAPT
SCHEMBL8897898 0.73 CYP1A2 (0.68) APPCYP1A2CYP3A4CYP2C19CLK4
SCHEMBL24150871 0.72 HTT (0.51) HTTAPPCYP1A2CYP3A4CYP2C19
SCHEMBL23723479 0.66 KMT2A (0.70) APPCYP1A2CYP3A4CYP2C19CLK4
SCHEMBL26530735 0.65 HTT (0.78) HTTAPPALDH1A1
SCHEMBL30378309 0.65 HTT (0.43) HTTAPPCYP1A2CYP3A4CYP2C19
SCHEMBL16519501 0.64 CYP1A1 (0.39) CYP1A2
SCHEMBL11243280 0.64 APP (0.62) APPCYP1A2CYP3A4CYP2C19CLK4
SCHEMBL7494193 0.64 PDE5A (0.70) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0579496-B1 4-Aminoquinazoline derivatives, and their use as medicine ONO PHARMACEUTICAL CO (JP) 2001-11-14 — — EP disclosed
US-5439895-A Cardiovascular disorders; inhibitor of thromboxane A2 synthetase and cyclic guanosine 3',5'-monophosphate ONO PHARMACEUTICAL CO., LTD. (JP) 1995-08-08 — — US disclosed
US-5436233-A Nervous system disorders ONO PHARMACEUTICAL CO., LTD. (JP) 1995-07-25 — — US disclosed
EP-0579496-A1 4-Aminoquinazoline derivatives, and their use as medicine ONO PHARMACEUTICAL CO., LTD. (JP) 1994-01-19 — — EP disclosed
Send feedback